We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGusbourne Regulatory News (GUS)

Share Price Information for Gusbourne (GUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.50
Bid: 58.00
Ask: 61.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.172%)
Open: 59.50
High: 59.50
Low: 59.50
Prev. Close: 59.50
GUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

19 Dec 2013 07:00

RNS Number : 8689V
Gusbourne PLC
19 December 2013
 



19 December 2013

 

Gusbourne Plc (the "Company")

Half Yearly Report

 

Gusbourne Plc today announces its unaudited interim results for the six months ended 30 September 2013

Gusbourne Plc (London-AIM: GUS) is engaged, via its wholly owned subsidiary Gusbourne Estate Limited ("Gusbourne Estate"), in the production and distribution of a range of high quality and award winning English sparkling and still wines from grapes grown in its own vineyards in Kent and West Sussex. The majority of Gusbourne Estate's mature vineyards are located at its 352 acre freehold estate at Appledore in Kent, where the winery is also based. Additional vineyards were planted in West Sussex in May 2013 and the Company now has a total of 105 acres (42 hectares) of vineyards under cultivation. The Company intends for further plantings to be undertaken over the next two years on Gusbourne Estate's freehold site in Kent.

The Company was incorporated in England & Wales on 24 September 2012 and was admitted to AIM on 25 October 2012 following the merger with Shellproof Limited. Details of this merger are set out in the Circular to Shareholders dated 10 October 2012.

On 27 September 2013 the Company completed the acquisition of the Gusbourne Estate business and related freehold property and, following that acquisition changed its name from Shellproof Plc to Gusbourne Plc. Details of this transaction are set out in the Circular to Shareholders dated 3 September 2013.

Results for the six months ended 30 September 2013

The trading results for the 6 months ended 30 September 2013 primarily reflect the activities of the Company prior to the acquisition of the Gusbourne Estate business on 27 September 2013.

The Company reported a consolidated net loss of ₤639,000 for the six months ended 30 September 2013 (2012 - profit of ₤33,000). This loss primarily comprised administration expenses of £630,000, of which £398,000 was represented by transaction expenses written off including stamp duty of £211,000. The vineyard operating costs of £122,000 were largely offset by the gain in the fair value of biological assets (vines), as accounted for under International Accounting Standard 41. The basic and diluted loss per ordinary share for the six months ended 30 September 2013 amounted to 7.93 pence (2012 - earnings per share of 0.41 pence).

The main changes to the Company's consolidated balance sheet since 31 March 2013 reflect the acquisition of the Gusbourne Estate business and the related freehold property on 27 September 2013. The total consideration for this acquisition amounted to £7,316,000, further details of which are contained in the Circular to Shareholders dated 3 September 2013 and also in Note 7 to the unaudited interim results below.

Board and senior management

Upon completion of the Gusbourne Estate acquisition, the board of the Company was enlarged by the appointments of Andrew Weeber, the founder and vendor of the Gusbourne Estate business, as non-Executive Chairman of the Company and by the appointment of Paul Bentham as a Non-Executive Director.

The Company's broader management team has also been enlarged with the successful integration of the two complementary management teams of the Gusbourne Estate business and Gusbourne Plc. This has provided an experienced and professional executive team which is well placed to further expand and develop the Gusbourne Estate business. 

Current trading and outlook

The sales of Gusbourne Estate's award winning sparkling and still wines are performing to expectations and media and consumer interest in the Company's products continues to be supported by the quality of its products and its continuing success in winning awards for them. On 13 November 2013 the Company was delighted to be presented with two awards from the long established and prestigious International Wine and Spirit Competition ("IWSC"). These two awards were for "English Wine Producer of the Year" and for "Best Bottle Fermented Sparkling Wine" for Gusbourne Estate Brut Reserve 2008.

This year's grape harvest at the Company's vineyards in Kent and Sussex took place later than usual as a result of the late start to the growing season. However, the yield volumes were excellent and more than double the Company's original expectations. The grapes harvested have continued to meet the unique quality expectations of Gusbourne Estate. The Company's winery, situated at its freehold estate in Kent, performed particularly well in dealing with the larger than expected volumes and these have added significant stocks of wine to the Company's inventory. Plans are well advanced for next year's planting of further vineyards on Gusbourne Estate's freehold estate in Kent.

The Company's growth strategy in this industry requires long term planning and the Company continues to make steady and pleasing progress towards its long term goals.

 

 

For further information contact:

Gusbourne Plc

Andrew Weeber/Ben Walgate/Ian Robinson +44 (0)1233 758 666

Cenkos Securities plc

Nicholas Wells +44 (0)20 7397 8900

Note: This announcement and other press releases are available to view at the Company's website: www.gusbourneplc.com

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the six months ended 30 September 2013

 

 

 

 

Unaudited

 

Unaudited

 

Audited

 

 

 

Six months to

Six months to

 

 Year ended

 

 

 

30 September

 

30 September

31 March

 

 

Notes

 

2013

 

2012

 

2013

 

 

 

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

 

Revenue

 

 

-

 

-

 

-

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

 

(122)

 

-

 

-

 

Gain in fair value less estimated costs to sell

 

 

 

 

 

 

 

 

of biological assets

 

 

102

 

-

 

1

 

Gross profit

 

 

(20)

 

-

 

1

 

 

 

 

 

 

 

 

 

 

 

Transactions expenses - stamp duty

8

 

(211)

 

-

 

-

 

Transactions expenses - other

8

 

(187)

 

-

 

(259)

 

Other administrative expenses

 

 

(232)

 

(69)

 

(352)

 

Total Administrative expenses

 

 

(630)

 

(69)

 

(611)

 

Loss from operations

 

 

(650)

 

(69)

 

(610)

 

 

 

 

 

 

 

 

 

 

Finance income

 

 

19

 

102

 

156

 

Finance expense

 

 

(8)

 

-

 

-

 

 

 

 

 

 

 

 

 

 

(Loss)/profit before tax

 

 

(639)

 

33

 

(454)

 

 

 

 

 

 

 

 

 

 

Tax expense

 

 

-

 

-

 

-

 

 

 

 

 

 

 

 

 

 

(Loss)/profit for the period attributable to

 

 

 

 

 

 

 

 

owners of the parent

 

 

(639)

 

33

 

(454)

 

 

 

 

 

 

 

 

 

 

(Loss)/earnings per share attributable to

 

 

 

 

 

 

 

 

the ordinary equity holders of the parent:

 

 

 

 

 

 

 

 

Basic

 

 

(7.93p)

 

0.41p

 

(5.68p)

 

Diluted

 

 

(7.93p)

 

0.41p

 

(5.68p)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

At 30 September 2013

 

Consolidated balance sheet

 

 

Unaudited

 

Unaudited

 

Audited

 

 

 

 

30 September

 

30 September

31 March

 

 

Notes

 

2013

 

2012

 

2013

 

Assets

 

 

£'000

 

£'000

 

£'000

 

Non-current assets

 

 

 

 

 

 

 

 

Property, plant and equipment

2

 

5,445

 

60

 

347

 

Goodwill

3

 

1,004

 

-

 

-

 

Biological assets

4

 

1,254

 

-

 

154

 

 

 

 

7,703

 

60

 

501

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

Inventories

5

 

1,015

 

135

 

137

 

Trade and other receivables

 

 

178

 

103

 

295

 

Cash and cash equivalents

 

 

2,770

 

4,046

 

3,128

 

 

 

 

3,963

 

4,284

 

3,560

 

 

 

 

 

 

 

 

 

 

Total assets

 

 

 

11,666

 

4,344

 

4,061

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Trade and other payables

 

 

(766)

 

(39)

 

(194)

 

Redeemable preference shares

 

 

-

 

-

 

(50)

 

 

 

 

(766)

 

(39)

 

(244)

 

 

 

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

 

 

Loans and borrowings

6

 

(3,777)

 

-

 

-

 

 

 

 

(3,777)

 

-

 

-

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

 

(4,543)

 

(39)

 

(244)

 

 

 

 

 

 

 

 

 

 

 

 

NET ASSETS

 

 

7,123

 

4,305

 

3,817

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issued capital and reserves attributable to

 

 

 

 

 

 

 

 

owners of the parent

 

 

 

 

 

 

 

 

Share capital

 

 

7,612

 

4,000

 

4,000

 

Share premium

 

 

346

 

-

 

266

 

Merger reserve

 

 

(13)

 

-

 

(266)

 

Retained earnings

 

 

(822)

 

305

 

(183)

 

 

 

 

 

 

 

 

 

 

TOTAL EQUITY

 

 

7,123

 

4,305

 

3,817

 

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF CASH FLOWS

For the six months ended 30 September 2013

 

 

 

 

 

 

Unaudited

 

Unaudited

 

Audited

 

 

 

 

Six months to Six months to

Six months to

 

Period to

 

 

 

 

 

30 September

 

30 September

31 March

 

 

 

 

 

2013

 

2012

 

2013

 

 

 

 

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

 

 

 

Cashflows from operating activities

 

 

 

 

 

 

 

 

 

 

(Loss)/profit for the period before tax

 

 

(639)

 

33

 

(454)

 

 

Adjustments for:

 

 

 

 

 

 

 

 

 

Depreciation of property, plant and equipment

 

 

12

 

8

 

18

 

 

(Profit)/loss on disposal of property, plant

 

 

 

 

 

 

 

 

 

and equipment

 

 

(8)

 

-

 

-

 

 

Finance income

 

 

(19)

 

(102)

 

(156)

 

 

Finance expense

 

 

8

 

-

 

-

 

 

Movement in fair value of biological assets

 

 

(102)

 

-

 

(1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(748)

 

(61)

 

(593)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Decrease/(Increase) in trade and other receivables

 

 

117

 

(82)

 

(275)

 

 

Increase in inventories

 

 

 

(2)

 

(51)

 

(53)

 

 

Increase/(Decrease) in trade and other payables

 

 

 

572

 

15

 

170

 

 

Cash generated from operations

 

 

687

 

(118)

 

(158)

 

 

 

 

 

 

 

 

 

 

 

 

Income taxes paid

 

 

-

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net cash flows from operating activities

 

 

(61)

 

 

(179)

 

(751)

 

 

 

 

 

 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(762)

 

-

 

(297)

 

 

Purchase of biological assets

 

 

-

 

-

 

(153)

 

 

Purchase of business and assets

 

 

(7,000)

 

-

 

-

 

 

Sale of property, plant and equipment

 

 

35

 

-

 

-

 

 

Net cash from investing activities

 

 

(7,727)

 

-

 

(450)

 

 

 

 

 

 

 

 

 

 

 

 

Financing activities

 

 

 

 

 

 

 

 

 

Proceeds from issue of share capital

 

 

3,901

 

-

 

-

 

 

Share issue expenses

 

 

(209)

 

-

 

-

 

 

Issue of redeemable preference shares

 

 

-

 

-

 

50

 

 

Redemption of preference shares

 

 

 

(50)

 

-

 

-

 

 

Proceeds from bank borrowings

 

 

2,025

 

-

 

-

 

 

Proceeds from issue of deep discount bond

 

 

1,750

 

-

 

-

 

 

Interest paid

 

 

(6)

 

-

 

-

 

 

Interest received

 

 

19

 

102

 

156

 

 

Net cash from financing activities

 

 

7,430

 

102

 

206

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF CASH FLOWS (continued)

For the six months ended 30 September 2013

 

 

 

 

 

 

Unaudited

 

Unaudited

 

Audited

 

 

 

Six months to Six months to

Six months to

 

Period to

 

 

 

 

30 September

 

30 September

31 March

 

 

 

 

2013

 

2012

 

2013

 

 

 

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net decrease in cash and cash equivalents

 

 

 

(358)

 

(77)

 

(995)

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

 

3,128

 

4,123

 

4,123

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

 

 

2,770

 

4,046

 

3,128

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the six months ended 30 September 2013

 

Audited Share

capital

Audited Share

premium

Audited Merger

reserve

Audited Retained

earnings

Audited Total

attributable

to equity

holders of

parent

£'000

£'000

£'000

£'000

£'000

31 March 2012

4,000

266

(266)

271

4,271

Comprehensive income for the year

(Loss)

-

-

-

(454)

(454)

______

______

______

______

______

Total comprehensive income for the year

-

-

-

(454)

(454)

______

______

______

______

______

31 March 2013

4,000

266

(266)

(183)

3,817

______

______

______

______

______

 

 

Unaudited Share

capital

Unaudited Share

premium

Unaudited Merger

reserve

Unaudited Retained

earnings

Unaudited Total

attributable

to equity

holders of

parent

£'000

£'000

£'000

£'000

£'000

31 March 2013

4,000

266

(266)

(183)

3,817

Comprehensive income for the year

(Loss)

-

-

-

(639)

(639)

Issue of ordinary shares

3,612

289

253

-

4,154

Share issue expenses

-

(209)

-

-

(209)

______

______

______

______

______

Total comprehensive income for the year

3,612

80

253

(639)

3,306

______

______

______

______

______

30 September 2013

7,612

346

(13)

(822)

7,123

______

______

______

______

______

 

 

 

 

 

 

 

NOTES TO THE ACCOUNTS

For the six months ended 30 September 2013

 

1 Statement of accounting policies

 

The interim financial statements have been prepared in accordance with the recognition and measurement principles as adopted by the EU, applying the accounting policies and presentation that were applied in the preparation of the Company's published consolidated financial statements for the year ended 31 March 2013.

 

The financial information for the six months ended 30 September 2013 has not been subject to an audit nor a review in accordance with International Standard on Review Engagements 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Auditing Practices Board. The comparative financial information presented herein for the year ended 31 March 2013 does not constitute full statutory accounts within the meaning of Section 434 of the Companies Act 2006. The Group's annual report and accounts for the year ended 31 March 2013 have been delivered to the Registrar of Companies. The Group's independent auditor's report was unqualified and did not include references to any matters to which the auditors drew attention by way of emphasis without qualifying their report and did not contain a statement under section 498(2) or 498(3) of the Companies Act 2006.

 

 

Basis of preparation

 

The Board of the Company continually assesses and monitors the key risks of the business. These risks have not significantly changed from those set out in the Company's Annual Report for the year ended 31 March 2013. The Board has reviewed forecasts and remains satisfied with the Company's funding and liquidity position. On the basis of its forecast and available facilities and cash balances held on the balance sheet, the Board has concluded that the going concern basis of preparation continues to be appropriate.

 

 

 

 

2 Property, plant and equipment

 

 

 

Unaudited

 

Unaudited

 

Audited

 

 

 

30 September

 

30 September

 

31 March

 

 

 

2013

 

2012

 

2013

 

 

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

Freehold property

 

4,585

 

-

 

222

 

Plant, machinery and motor vehicles

 

420

 

60

 

83

 

Vineyard expenditure

 

427

 

-

 

40

 

Computer equipment

 

13

 

-

 

2

 

 

 

5,445

 

60

 

347

 

 

 

The additions in the period include £4,363,000 of Freehold land and buildings, £71,000 of plant, machinery and motor vehicles and £5,000 of computer equipment which were acquired as part of the acquisition of the Gusbourne Estate business and related freehold property on 27 September 2013.

 

Vineyard expenditure includes planting expenditure in relation to vineyards which are carried forward at cost until the vines reach maturity at which point they are re-measured and transferred to biological assets.

 

 

 

 

 

 

NOTES TO THE ACCOUNTS (continued)

For the six months ended 30 September 2013

 

3 Goodwill

 

 

 

Unaudited

 

Unaudited

 

Audited

 

 

 

30 September

 

30 September

 

31 March

 

 

 

2013

 

2012

 

2013

 

 

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

Goodwill

 

1,004

 

-

 

-

 

 

 

1,004

 

-

 

-

 

 

Goodwill arose on the acquisition of the Gusbourne Estate business and related Freehold Property and has been calculated as the difference between the fair value of the consideration paid and the provisional fair value of the assets and liabilities acquired. The goodwill has been capitalised and impairment tests are carried out at reporting dates.

 

 

4 Biological assets

 

 

 

 

 

 

 

 

Vines

 

 

 

 

 

 

 

 

£'000

 

 

 

 

 

 

 

 

 

 

At 1 April 2012

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Additions

 

 

 

 

 

 

153

 

Change in fair value

 

 

 

 

 

 

1

 

 

 

 

 

 

 

 

 

 

At 31 March 2013

 

 

 

 

 

 

154

 

 

 

 

 

 

 

 

 

 

Acquisitions

 

 

 

 

 

 

998

 

Change in fair value

 

 

 

 

 

 

102

 

 

 

 

 

 

 

 

 

 

At 30 September 2013

 

 

 

 

 

 

1,254

 

 

 

 

 

 

 

 

 

 

 

 

Acquisitions in the period comprise biological assets which were acquired as part of the acquisition of the Gusbourne Estate business and related freehold property which completed on 27 September 2013.

 

5 Inventories

 

 

Unaudited

 

Unaudited

 

Audited

 

 

 

30 September

 

30 September

 

31 March

 

 

 

2013

 

2012

 

2013

 

 

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

Raw materials and consumables

 

36

 

-

 

-

 

Wine

 

979

 

135

 

137

 

 

 

1,015

 

135

 

137

 

 

NOTES TO THE ACCOUNTS (continued)

For the six months ended 30 September 2013

 

6 Loans and borrowings - non-current

 

 

 

 

Unaudited

 

Unaudited

 

Audited

 

 

 

 

30 September

 

30 September

 

31 March

 

 

 

 

2013

 

2012

 

2013

 

 

 

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

 

Bank loan ( secured)

 

 

2,025

 

-

 

-

 

Deep discount bond (secured)

 

 

1,752

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

3,777

 

-

 

-

 

 

The secured bank loan is repayable after 5 years, and is subject to an interest rate of 3% above Barclays' base rate. It is secured by a cross guarantee and debenture granted by Gusbourne Estate Limited and the Company, a legal charge granted by Gusbourne Estate Limited and a charge over a cash deposit granted by the Company.

 

Thesecured deep discount bond was issued by the Company at a subscription priceof £1,750,000. The bond has a 4 year term and is redeemable at its nominal price of £2,337,518 on 27 September 2017. The bond may be redeemed early, subject to certain conditions. Between27 September 2015 and 27 September 2016, the bond holders have the option to convert some or all of the bonds into the Company's Shares, at a price of 66 pence per share. The bond is secured by debentures granted by the Company and Gusbourne Estate Limited and a legal charge granted by Gusbourne Estate Limited.

 

7 Business combinations

 

On 27 September 2013, Gusbourne Estate Limited, a wholly owned subsidiary of the Company acquired the Gusbourne Estate business and related Freehold Property for a total consideration of £7,316,000, which includes contingent consideration of £63,000.

 

 

 

 

 

 

 

 

Unaudited

 

 

 

 

 

 

 

 

Provisional fair value at acquisition

 

 

 

 

 

 

 

 

£'000

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment

 

 

 

 

 

 

4,439

 

Biological Assets

 

 

 

 

 

 

998

 

Inventories

 

 

 

 

 

 

875

 

Net assets acquired

 

 

 

 

 

 

6,312

 

Goodwill

 

 

 

 

 

 

1,004

 

Consideration

 

 

 

 

 

 

7,316

 

 

 

 

 

 

 

 

 

 

Satisfied by:

 

 

 

 

 

 

 

 

Cash to vendors

 

 

 

 

 

 

4,200

 

Deep discount bond issued to the vendors

 

 

 

 

 

 

1,750

 

Market value of shares issued to the vendors

 

 

 

 

 

 

1,303

 

Contingent consideration

 

 

 

 

 

 

63

 

Consideration

 

 

 

 

 

 

7,316

 

 

Fair values are provisional and will continue to be reviewed in the 12 months following the acquisition.

 

 

NOTES TO THE ACCOUNTS (continued)

For the six months ended 30 September 2013

 

8 Transaction expenses

 

Transaction expenses for the period to 30 September 2013 represent expenses incurred in connection with the acquisition of the Gusbourne Estate business and related Freehold Property. Transaction expenses for the period to 31 March 2013 represent expenses incurred in connection with the merger, on 24 October 2012, with Shellproof Limited.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR UWRUROWAUAAA
Date   Source Headline
31st Jan 20247:00 amRNSTrading Statement
19th Jan 20244:20 pmRNSRefinancing of existing loan facilities
17th Jan 20247:00 amRNSBoard Changes and CEO Designate Appointment
4th Jan 202412:26 pmRNSIssue of Equity
21st Dec 20237:00 amRNSAuditor Change
30th Nov 20237:00 amRNSDirectorate Change
14th Nov 20237:00 amRNSShort term Unsecured Loan & Extension of Warrants
3rd Nov 20233:00 pmRNSIssue of Equity
26th Oct 20237:00 amRNSWarrant Exercise/PDMR Dealings
19th Oct 20237:00 amRNSHarvest Report
28th Sep 20237:00 amRNSInterim results to 30 June 2023
6th Sep 20237:00 amRNSBoard Change and Appointment of Interim CEO
1st Sep 20237:00 amRNSIssue of Equity
29th Jun 20232:42 pmRNSResult of AGM
27th Jun 20237:00 amRNSBoard Change
7th Jun 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSDirectorate Change
14th Feb 202312:12 pmRNSAIM Rule 17 Notification
31st Jan 20237:00 amRNSTrading Update
16th Jan 20231:32 pmRNSIssue of Equity
20th Dec 20227:00 amRNSGrant of Share Options
16th Dec 202210:30 amRNSIssue of Equity
14th Dec 20227:00 amRNSExtension of the final exercise date of Warrants
27th Oct 20227:00 amRNSHarvest Report
4th Oct 20221:51 pmRNSIssue of Equity
29th Sep 20227:00 amRNSInterim results to 30 June 2022
6th Sep 20227:00 amRNSChange of Adviser
22nd Aug 20227:00 amRNSDirectorate Change
15th Aug 20227:00 amRNSTrading Update, Refinancing & Land Purchase
30th Jun 20222:00 pmRNSResult of AGM
6th Jun 20227:00 amRNSFinal Results
3rd May 202210:15 amRNSIssue of Equity
29th Mar 202212:10 pmRNSIssue of Equity
2nd Mar 20229:30 amRNSIssue of Equity
10th Feb 20227:00 amRNSTrading Update
17th Dec 20217:00 amRNSCompletion of Warrant Issue
15th Dec 20213:50 pmRNSFurther re Issue of Warrants
15th Dec 20217:00 amRNSResult of Open Offer and Issue of Warrants
22nd Nov 20217:00 amRNSLaunch of Open Offer and Posting of Circular
2nd Nov 20214:34 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSResult of Warrant Exercise and Debt Conversion
18th Oct 20214:30 pmRNSApplication for Admission
18th Oct 20212:10 pmRNSResult of ABB
18th Oct 20217:01 amRNSPlacing and Subscription
18th Oct 20217:00 amRNSFunding Update
30th Sep 20217:00 amRNSInterim Results to 30 June 2021
10th Aug 20217:38 amRNSIssue of Equity
23rd Jul 20217:00 amRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSTrading and Capital Structure Update
19th Jul 20211:00 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.